Erratum: First‐in‐class pyrido[2, 3‐d]pyrimidine‐2, 4(1H, 3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights. Issue 4 (1st March 2022) - Ramesh, Deepthi